Cargando…
中国服用酪氨酸激酶抑制剂的慢性髓性白血病慢性期患者共存疾病状况及其对患者报告结果的影响
OBJECTIVE: To explore the comorbidity profile and its impact on reported outcome of patients with chronic myeloid leukemia in chronic phase (CML-CP) receiving tyrosine kinase-inhibitor (TKI) therapy in China. METHODS: From September 2015 to March 2016, anonymous questionnaires were distributed to ad...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342205/ https://www.ncbi.nlm.nih.gov/pubmed/30122010 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.07.002 |